— Know what they know.
Not Investment Advice
Also trades as: ENLV.TA (TLV) · $vol 0M

ENLV Dark Pool Activity

Enlivex Therapeutics Ltd.
1W: -22.7% 1M: -73.2% 3M: -92.8% YTD: -98.6% 1Y: -99.0% 3Y: -99.3% 5Y: -99.9%
$2.70
+0.10 (+3.72%)
After Hours: $2.67 (-0.03, -1.11%)
Weekly Expected Move ±14.7%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · $2.7M mcap · 17M float · 4.68% daily turnover · Short 26% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 86.3% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.11 (down 34%), Enlivex Therapeutics Ltd. would be worth roughly what it owes.
Total debt $17.2M against a stock market value of $2.7M.
Distance to default 0.43 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $16.9M (short-term plus half of long-term), stock volatility 108.5%; Altman Z'' 11.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
No dark pool data available for ENLV.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms